List view / Grid view
23 April 2018 | By European Pharmaceutical Review
Researchers have developed a highly specific apoptosis assay designed for immunofluorescence microscopy analysis of fixed core needle biopsy specimens...
13 April 2018 | By European Pharmaceutical Review
In this In-Depth Focus; early biotherapeutic lead optimisation for more efficient drug discovery and development, and turning promising compounds into drug candidates.
1 March 2018 | By Dr Payam Behzadi
In parallel with the use of a wide range of antibiotics for treating infectious diseases worldwide, antimicrobial resistance has significantly increased. For this reason, the application of an advanced pangenomic technique like DNA microarray can be an effective, rapid, accurate, sensitive, specific and flexible methodology for detecting, identifying and determining…
5 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have systematically analysed and quantified the interactions of all proteins with metabolites on the level of the whole proteome...
4 January 2018 | By Johan Devenyns, Johan Devenyns - PharmaFluidics
Much rests on the further development of bioanalytical technologies which allow the highest level of sensitivity on small samples, and robust, high reproducibility across large populations. Johan Devenyns, CEO PharmaFluidics, explains further...
15 December 2017 | By David Keller
Designing appropriate non-clinical safety studies requires thoughtful, and sometimes experimental, consideration of the delivery methodology for the therapeutic. The choice of formulation affects drug release and absorption and has a direct impact on the pharmacokinetic profile and associated response of the model system. The formulation should be compatible with the…
8 December 2017 | By European Pharmaceutical Review
A team of researchers set out to discover the disease pathways of a rare genetic kidney disease and consequently found a compound that stops the disease in its tracks.
29 November 2017 | By Abbvie Contract Manufacturing
State-of-the-art contract manufacturing...
29 November 2017 | By FUJIFILM Diosynth Biotechnologies
Technical leadership in contract development and manufacturing...
21 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Boehringer Ingelheim has announced the launch of a new platform offering free and open access to selected pre-clinical molecules for a non-clinical investigation to scientists worldwide...
15 November 2017 | By Quotient Sciences
Quotient Clinical, the drug development services organisation, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS Pharma and SeaView Research...
19 October 2017 | By European Pharmaceutical Review
The European Pharmacopoeia chapter on methods for microbiological quality control was recently revised to include a number of significant changes. In this In-Depth Focus Michael Miller provides the first part of this two-part review and Kevin Williams discusses a paradigm change in biologics microbiological contaminant control.
6 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have found that polymer and hybrid silica-coated microcapsules are efficient in genome-editing...
5 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
TK216-vincristine combination appears to halt the ability of Ewing sarcoma to grow and progress...
27 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment...
Send this to a friend
Follow: